Strategic partnerships Corgenix operates as a contract development and manufacturing organization (CDMO) with experience across IVD development, quality control, regulatory compliance and manufacturing. This suggests strong potential to upsell additional services such as assay development, regulatory consulting, and manufacturing scale-up for biotech and pharma clients seeking end-to-end support.

Regulatory credibility With ISO-13485:2016 certification, FDA registration and GMP compliance, as well as CAP/CLIA accreditation, Corgenix demonstrates robust quality and compliance credentials. This positions them as a reliable partner for sponsors who require stringent quality systems, enabling cross-selling into high-stakes clinical trial testing and regulatory-driven programs.

Clinical trial network Their focus on clinical studies, trial management, and physician-ordered patient testing indicates access to a network of Biotech, Pharmaceutical, Cancer Centers and Academic labs. This offers sales opportunities to expand existing collaborations or introduce additional assay kits, biomarker services, or diagnostic product lines to ongoing trial programs.

Global capabilities Despite a small staff, Corgenix presents as a nimble partner with a broad capability set, including warehousing, distribution and commercialization support. This versatility can appeal to sponsors seeking integrated logistics and post-market support for diagnostic products in varied geographic markets.

Strategic alliances Historical collaborations with large entities (e.g., Lilly) and NIH-funded rapid diagnostics projects indicate a track record of co-development and commercialization partnerships. This history can be leveraged to pursue new co-development deals or milestone-based contracts with biotech and pharma firms pursuing innovative diagnostic solutions.